Literature DB >> 11259788

A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide.

V Jevtovic-Todorovic1, D F Wozniak, N D Benshoff, J W Olney.   

Abstract

The general anesthetics, nitrous oxide (N(2)O) and ketamine, are NMDA antagonists which, like other NMDA antagonists such as MK801, induce a neurotoxic reaction in the rat brain. For MK801 neurotoxicity, both age and sex are important variables (adult rats are more sensitive than immature rats and females are more sensitive than males). In this study we found that ketamine has this same age and sex dependency profile, and N(2)O has the same age but not sex dependency. Male and female rats are equally sensitive to N(2)O neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259788     DOI: 10.1016/s0006-8993(01)02079-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  31 in total

Review 1.  Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.

Authors:  Daniel C Mathews; Ioline D Henter; Carlos A Zarate
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

Review 2.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

3.  Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome.

Authors:  Michael E Goldberg; Marc C Torjman; Robert J Schwartzman; Donald E Mager; Irving W Wainer
Journal:  Pain Physician       Date:  2010 Jul-Aug       Impact factor: 4.965

4.  Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain.

Authors:  Catherine E Creeley; David F Wozniak; Anthony Nardi; Nuri B Farber; John W Olney
Journal:  Neurobiol Aging       Date:  2006-11-16       Impact factor: 4.673

5.  Greater vulnerability to the amnestic effects of ketamine in males.

Authors:  Celia J A Morgan; Edward B Perry; Hyung-Sang Cho; John H Krystal; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2006-08-01       Impact factor: 4.530

6.  Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression.

Authors:  Marlene P Freeman; George I Papakostas; Bettina Hoeppner; Erica Mazzone; Heidi Judge; Cristina Cusin; Sanjay Mathew; Gerard Sanacora; Dan Iosifescu; Charles DeBattista; Madhukar H Trivedi; Maurizio Fava
Journal:  J Psychiatr Res       Date:  2019-01-08       Impact factor: 4.791

7.  Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system.

Authors:  Brian P Head; Hemal H Patel; Ingrid R Niesman; John C Drummond; David M Roth; Piyush M Patel
Journal:  Anesthesiology       Date:  2009-04       Impact factor: 7.892

8.  GABAergic mechanism of propofol toxicity in immature neurons.

Authors:  Sibel Kahraman; Susan L Zup; Margaret M McCarthy; Gary Fiskum
Journal:  J Neurosurg Anesthesiol       Date:  2008-10       Impact factor: 3.956

9.  Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism.

Authors:  Valentina Gigliucci; Grainne O'Dowd; Sheena Casey; Danielle Egan; Sinead Gibney; Andrew Harkin
Journal:  Psychopharmacology (Berl)       Date:  2013-03-02       Impact factor: 4.530

10.  Feasibility and pilot study of the Pediatric Anesthesia NeuroDevelopment Assessment (PANDA) project.

Authors:  Lena S Sun; Guohua Li; Charles J DiMaggio; Mary W Byrne; Caleb Ing; Tonya L K Miller; David C Bellinger; Sena Han; Francis X McGowan
Journal:  J Neurosurg Anesthesiol       Date:  2012-10       Impact factor: 3.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.